NAVLE Gastrointestinal and Digestive

Equine Coronavirus Enteritis Study Guide

📅 March 28, 2026 ⏱ 25 min read

Equine coronavirus (ECoV) is an emerging enteric pathogen of adult horses that has been reported with increasing frequency since 2010.

Overview and Clinical Importance

Equine coronavirus (ECoV) is an emerging enteric pathogen of adult horses that has been reported with increasing frequency since 2010. Unlike other species where coronaviruses primarily cause respiratory disease, ECoV in horses predominantly targets the gastrointestinal tract. This single-stranded, positive-sense RNA virus belongs to the Betacoronavirus genus and is genetically related to bovine coronavirus (BCoV).

ECoV is clinically significant because it causes outbreaks at equine facilities with high morbidity rates (10-83%), although mortality is generally low. The disease is characterized by fever, anorexia, and lethargy, with less frequent gastrointestinal signs such as colic and diarrhea. Understanding this emerging pathogen is essential for the NAVLE, particularly regarding differential diagnosis of adult horse enterocolitis.

High-YieldECoV primarily affects ADULT horses (greater than 2 years old) as a mono-infection, while in foals it is typically seen as a co-infection with rotavirus or Clostridium perfringens. This is a key distinguishing feature from other enteric pathogens.

Characteristic	Description
Classification	Betacoronavirus genus, closely related to BCoV
Genome	Single-stranded, positive-sense RNA
Envelope	Enveloped (susceptible to common disinfectants)
Primary Tropism	Intestinal epithelium (enterocytes)
Environmental Survival	Estimated 2-3 days; longer at cooler temperatures

Etiology and Viral Characteristics

Equine coronavirus is a member of the family Coronaviridae, subfamily Coronavirinae, genus Betacoronavirus. The virus is characterized as a single-stranded, positive-sense, non-segmented, enveloped RNA virus. ECoV is closely related to bovine coronavirus (BCoV) and shares significant genetic homology with human coronavirus strains OC43 and HKU1.

Key Viral Features

NAVLE TipUnlike bovine coronavirus which causes both respiratory and enteric disease, ECoV shows minimal tropism for equine respiratory epithelium. This is why nasal shedding is rare despite fecal shedding being common.

Parameter	Value/Description
Incubation Period	48-72 hours
Fecal Shedding Onset	3-4 days post-exposure
Peak Shedding	3-4 days after clinical signs appear
Shedding Duration	Typically 3-25 days; documented up to 99 days
Morbidity Rate	10-83% (variable)
Mortality Rate	Generally low; up to 27% in miniature horses
Outbreak Duration	Approximately 3 weeks
US Seroprevalence	Approximately 9.3%

Epidemiology

Transmission

ECoV is transmitted via the fecal-oral route. Horses become infected by ingesting fecally contaminated feed, water, or environmental materials. The virus is highly contagious, and outbreaks spread rapidly when biosecurity measures are not implemented promptly.

Key Epidemiological Parameters

Risk Factors and Predispositions

Age: Clinical disease predominantly affects adult horses (greater than 2 years). In foals, ECoV is typically found as a co-infection.

Breed: No definitive breed predisposition, but American Miniature Horses appear to have increased susceptibility to severe disease and higher case fatality rates (up to 27%).

Seasonality: Cases occur year-round but are more frequent during colder months (October through April in the Northern Hemisphere).

Management: Racing, riding, and show horses are more commonly affected than breeding animals, likely due to frequent movement and mixing at events.

High-YieldHorses may test fecal PCR NEGATIVE during very early clinical disease because shedding begins 3-4 days post-exposure while clinical signs appear at 48-72 hours. Consider repeat testing if initial results are negative but suspicion remains high.

Clinical Sign	Frequency	Category
Anorexia	97%	Systemic
Lethargy/Depression	88%	Systemic
Fever	83%	Systemic
Changes in fecal character	Less than 20%	Enteric
Colic signs	Less than 20%	Enteric
Diarrhea	~10%	Enteric
Neurologic signs	~3%	Complication

Clinical Signs and Presentation

Clinical presentation of ECoV is often characterized by nonspecific systemic signs, with enteric signs present in less than 20% of infected cases. The disease is typically self-limiting, resolving within several days to one week with supportive care.

Frequency of Clinical Signs

Neurologic Signs (Hyperammonemic Encephalopathy)

In approximately 3% of cases, horses develop hyperammonemia-associated encephalopathy. This complication occurs secondary to increased ammonia production by overgrowth of urease-producing bacteria or increased absorption through a disrupted intestinal mucosal barrier.

Neurologic signs include: head pressing, aimless circling, ataxia, proprioceptive deficits, nystagmus, decreased mentation, recumbency, and seizures.

NAVLE TipWhen you see a horse with fever, anorexia, and encephalopathic signs (head pressing, circling), think ECoV with hyperammonemia. Always measure blood ammonia in any horse with suspected ECoV and neurologic signs. Reference range is typically 60 micromol/L or less; severe cases may reach 677 micromol/L.

Complication	Mechanism and Features
Endotoxemia	Bacterial translocation through damaged intestinal barrier; causes systemic inflammatory response
Septicemia	Bacterial invasion of bloodstream; may require antimicrobial therapy
Hyperammonemic Encephalopathy	Overgrowth of urease-producing bacteria or increased ammonia absorption; causes Alzheimer type II astrocytosis in brain
Necrotizing Enteritis	Severe villous atrophy, crypt necrosis, pseudomembrane formation; rare but often fatal
Laminitis	Secondary to endotoxemia; reported in colitis cases

Complications

While most ECoV infections are self-limiting, severe complications can occur due to disruption of the gastrointestinal barrier:

High-YieldMiniature horses have higher case fatality rates (up to 27% vs typically less than 7%). This apparent increased susceptibility needs further investigation, but miniatures presenting with ECoV should be monitored more closely for complications.

Finding	Frequency	Clinical Significance
Leukopenia	~74%	Viral hemogram indicator
Neutropenia	~66%	Most consistent finding
Lymphopenia	~72%	Supports viral etiology
Unremarkable CBC	~10%	Does not rule out ECoV

Diagnosis

Clinical Approach

A presumptive diagnosis of ECoV should be considered when multiple adult horses present with fever, anorexia, and lethargy with or without gastrointestinal signs, particularly if hematological changes are consistent with viral infection.

Laboratory Findings

Hematology

Biochemistry

Biochemical parameters may be unremarkable but can include: elevated total and indirect bilirubin (due to anorexia), electrolyte changes consistent with enterocolitis, transient elevation of liver enzymes, and prerenal azotemia. Blood ammonia should be measured in any horse with neurologic signs.

Confirmatory Diagnostics

Exam Focus: Fecal qPCR is the diagnostic test of choice for ECoV. Remember that approximately 18% of samples submitted for ECoV testing are positive. Sample handling is critical - keep samples chilled and freeze if submission is delayed beyond 3-4 days.

Test	Sample/Method	Notes
Fecal qPCR	Fresh feces; keep chilled; freeze if delayed more than 3-4 days	Gold standard; ~3 business days; highest sensitivity
Electron Microscopy	Feces or intestinal tissue	Less sensitive than PCR; identifies viral particles
Antigen-Capture ELISA	Feces	Less sensitive than PCR
Immunohistochemistry	Intestinal tissue (post-mortem or biopsy)	Uses bovine coronavirus antiserum; detects antigen in enterocytes
Serology (ELISA)	Serum; S1 protein-based	Indicates exposure; useful for epidemiologic studies

Differential Diagnosis

ECoV shares clinical features with other causes of equine enterocolitis. A comprehensive enteric panel should be submitted to rule out other pathogens.

NAVLE TipECoV and Salmonella share remarkably similar clinical features. Both cause fever, anorexia, and enteric signs with leukopenia. Always include both on your differential list for adult horses with enterocolitis. The key differences: ECoV rarely causes severe diarrhea (less than 20% vs common in Salmonella), and Salmonella is zoonotic.

Pathogen	Key Distinguishing Features	Diagnostic Test
Salmonella spp.	Similar presentation; more severe leukopenia; zoonotic potential	Fecal culture (5 consecutive samples) or PCR
Potomac Horse Fever	Endemic areas; summer/fall; laminitis risk; responds to tetracyclines	PCR (blood and feces) for Neorickettsia risticii
Clostridioides difficile	Often post-antimicrobial; toxin-mediated; may have prior drug history	Fecal PCR for toxin genes A and B
Clostridium perfringens	Acute hemorrhagic diarrhea; high mortality; necrotizing enteritis	Fecal culture and enterotoxin detection
NSAID Toxicity	History of NSAID use; right dorsal colitis; oral and gastric ulceration	Clinical history; exclusion of infectious causes
Lawsonia intracellularis	Weanlings/yearlings; weight loss; hypoproteinemia	Fecal PCR; serology

Pathology

Gross Pathology

In fatal cases, gross lesions include fluid, red-tinged small intestinal contents and diffuse reddening of jejunal and ileal mucosa. The mucosa may be covered by a thin, friable, adherent pseudomembrane.

Histopathology

ECoV-infected equids display severe diffuse necrotizing enteritis with characteristic lesions:

Marked villous attenuation
Epithelial cell necrosis at villous tips
Neutrophilic and fibrinous extravasation into small intestinal lumen (pseudomembrane)
Crypt necrosis ("crypt microabscesses") - distinctive feature
Microthrombosis and mucosal hemorrhage

Brain Pathology (Hyperammonemic Encephalopathy)

Horses with hyperammonemic encephalopathy show Alzheimer type II astrocytosis throughout the cerebral cortex.

High-YieldThe presence of CRYPT NECROSIS (crypt microabscesses) is a distinctive histopathologic feature that should raise suspicion for ECoV. This distinguishes it from other equine enteropathogens where crypt involvement is less prominent.

Severity	Clinical Presentation	Treatment Approach
Mild	Fever, anorexia, depression; normal hydration	NSAIDs (flunixin meglumine 0.5-1.1 mg/kg IV/PO q12-24h OR phenylbutazone 2-4 mg/kg IV/PO q12-24h) for 24-48 hours
Moderate	Persistent signs; colic; diarrhea; dehydration	IV or enteral polyionic fluids; electrolyte replacement; NSAIDs; GI protectants
Severe (Endotoxemia/Septicemia)	Signs of systemic inflammatory response; toxic mucous membranes	Aggressive IV fluids; antimicrobials; polymyxin B; GI protectants; laminitis prophylaxis (cryotherapy)
Neurologic (Hyperammonemia)	Head pressing, circling, ataxia, decreased mentation, seizures	Lactulose 0.1-0.2 mL/kg PO q6-12h; neomycin sulfate 4-8 mg/kg PO q8h; fecal transfaunation; crystalloid fluids

Treatment

There are no specific antiviral drugs for ECoV. Treatment is primarily supportive, and the disease is typically self-limiting in uncomplicated cases.

Treatment Protocols by Severity

Drug Summary Table

NAVLE TipFor horses with suspected hyperammonemia, early treatment with LACTULOSE is key. Lactulose acidifies colonic contents, traps ammonia as ammonium ion, and promotes excretion. Neomycin reduces urease-producing bacterial populations. Fecal transfaunation can help restore normal intestinal flora.

Drug	Dose	Route/Frequency	Indication
Flunixin meglumine	0.5-1.1 mg/kg	IV or PO q12-24h	Fever, pain, endotoxemia
Phenylbutazone	2-4 mg/kg	IV or PO q12-24h	Fever, pain
Lactulose	0.1-0.2 mL/kg	PO q6-12h	Hyperammonemia
Neomycin sulfate	4-8 mg/kg	PO q8h	Hyperammonemia (reduces urease bacteria)

Prevention and Biosecurity

There is currently no licensed vaccine for ECoV. Prevention relies entirely on biosecurity measures and early detection.

Key Biosecurity Measures

Isolation: Immediately isolate any horse with fever, anorexia, and depression until diagnosis confirmed
Quarantine: New arrivals should be isolated for at least 3 weeks
Temperature monitoring: Twice daily rectal temperatures for at-risk horses
Dedicated equipment: Separate feeding, cleaning, and handling equipment for isolated horses
Personnel hygiene: Handle isolated horses last; use footbaths; wear protective clothing; hand hygiene
Disinfection: ECoV is susceptible to common disinfectants including sodium hypochlorite, povidone-iodine, chlorhexidine, quaternary ammonium compounds, and accelerated hydrogen peroxide
Post-infection testing: Test recovered horses before removing from isolation (shedding can continue weeks beyond clinical resolution)

High-YieldHorses can shed ECoV in feces for WEEKS after clinical recovery (typically 3-25 days, up to 99 days documented). Asymptomatic shedders exist and can spread disease. This is why post-infection testing is crucial before ending isolation.

Prognosis

The prognosis for ECoV infection is generally good. Most horses recover within several days to one week with supportive care. Mortality rates are typically low (0-7% in most outbreaks), although American Miniature Horses may experience higher case fatality rates (up to 27%).

Negative prognostic indicators: higher fecal viral load, neurologic signs (encephalopathy), severe hyperammonemia, signs of endotoxemia/septicemia, and miniature horse breed.

ECoV = "E.C.O.V." Mnemonic

E = Enteric (not respiratory like other species)

C = Cold months (October-April peak)

O = Older horses (adults greater than 2 years, mono-infection)

V = Viral hemogram (leukopenia with neutropenia and lymphopenia)

"MINI" - High Risk Group

MINIature horses have MINImal chances with MAXImum mortality (up to 27%)

"FAL" - Classic Triad

Fever (83%)

Anorexia (97%)

Lethargy (88%)

Remember: Diarrhea is INfrequent (less than 20%) - This is NOT your typical "diarrhea disease"!

Practice NAVLE Questions

Test your knowledge with 10,000+ exam-style questions, detailed explanations, and timed exams.

Start Your Free Trial →